Laddar...
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
Multiple kinase inhibitors are available for patients with advanced hepatocellular carcinoma (HCC). It is largely unknown whether regorafenib or lenvatinib modulates innate immunity including Toll-like receptor (TLR)-signaling pathways in HCC. We performed real-time RT-PCR to investigate 84 TLR-asso...
Sparad:
| I publikationen: | Int J Mol Sci |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246870/ https://ncbi.nlm.nih.gov/pubmed/32397371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093349 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|